Our finding that EG3287 combined with chemotherapy in lung A549 and prostate DU145 cells prevented fibronectin-dependent chemoresistance, indicates that the mechanism underlying NRP1-mediated chemoresistance is mediated in part through the integrin-dependent interaction of carcinoma cells with the ECM. The gene discussed is NRP1; the disease is carcinoma.